These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35940020)

  • 21. Thalamic atrophy and cognitive impairment in clinically isolated syndrome and multiple sclerosis.
    Štecková T; Hluštík P; Sládková V; Odstrčil F; Mareš J; Kaňovský P
    J Neurol Sci; 2014 Jul; 342(1-2):62-8. PubMed ID: 24819917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and MRI predictors of cognitive decline in patients with relapsing-remitting multiple sclerosis: A 2-year longitudinal study.
    Dong X; Xu G; Wang J; Yin N; Meng N
    Mult Scler Relat Disord; 2022 Sep; 65():103838. PubMed ID: 35749960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneous pathological processes account for thalamic degeneration in multiple sclerosis: Insights from 7 T imaging.
    Louapre C; Govindarajan ST; Giannì C; Madigan N; Sloane JA; Treaba CA; Herranz E; Kinkel RP; Mainero C
    Mult Scler; 2018 Oct; 24(11):1433-1444. PubMed ID: 28803512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grey matter atrophy in patients with benign multiple sclerosis.
    Niiranen M; Koikkalainen J; Lötjönen J; Selander T; Cajanus A; Hartikainen P; Simula S; Vanninen R; Remes AM
    Brain Behav; 2022 Jul; 12(7):e2679. PubMed ID: 35765699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalamic atrophy and dysconnectivity are associated with cognitive impairment in a multi-center, clinical routine, real-word study of people with relapsing-remitting multiple sclerosis.
    Zivadinov R; Bergsland N; Jakimovski D; Weinstock-Guttman B; Lorefice L; Schoonheim MM; Morrow SA; Ann Picone M; Pardo G; Zarif M; Gudesblatt M; Nicholas JA; Smith A; Hunter S; Newman S; AbdelRazek MA; Hoti I; Riolo J; Silva D; Fuchs TA; Dwyer MG; Hb Benedict R
    Neuroimage Clin; 2024; 42():103609. PubMed ID: 38718640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalamic atrophy correlates with dysfunctional impulsivity in multiple sclerosis.
    Joly H; Capet N; Mondot L; Cohen M; Suply C; Bresch S; Lebrun-Frenay C
    Mult Scler Relat Disord; 2020 Sep; 44():102374. PubMed ID: 32652509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential association of cortical, subcortical and spinal cord damage with multiple sclerosis disability milestones: A multiparametric MRI study.
    Hidalgo de la Cruz M; Valsasina P; Meani A; Gallo A; Gobbi C; Bisecco A; Tedeschi G; Zecca C; Rocca MA; Filippi M
    Mult Scler; 2022 Mar; 28(3):406-417. PubMed ID: 34124963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 7T MRI cerebral leptomeningeal enhancement is common in relapsing-remitting multiple sclerosis and is associated with cortical and thalamic lesions.
    Zurawski J; Tauhid S; Chu R; Khalid F; Healy BC; Weiner HL; Bakshi R
    Mult Scler; 2020 Feb; 26(2):177-187. PubMed ID: 31714181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vulnerability of Thalamic Nuclei at CSF Interface During the Entire Course of Multiple Sclerosis.
    Koubiyr I; Yamamoto T; Blyau S; Kamroui RA; Mansencal B; Planche V; Petit L; Saranathan M; Casey R; Ruet A; Brochet B; Manjón JV; Dousset V; Coupé P; Tourdias T;
    Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200222. PubMed ID: 38635941
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subcortical and cortical gray matter atrophy in a large sample of patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
    Bergsland N; Horakova D; Dwyer MG; Dolezal O; Seidl ZK; Vaneckova M; Krasensky J; Havrdova E; Zivadinov R
    AJNR Am J Neuroradiol; 2012 Sep; 33(8):1573-8. PubMed ID: 22499842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the genetic contribution to brain magnetic resonance imaging lesion load and atrophy measures in multiple sclerosis patients.
    Clarelli F; Assunta Rocca M; Santoro S; De Meo E; Ferrè L; Sorosina M; Martinelli Boneschi F; Esposito F; Filippi M
    Eur J Neurol; 2021 Aug; 28(8):2513-2522. PubMed ID: 33864731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thalamic damage and long-term progression of disability in multiple sclerosis.
    Rocca MA; Mesaros S; Pagani E; Sormani MP; Comi G; Filippi M
    Radiology; 2010 Nov; 257(2):463-9. PubMed ID: 20724544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal associations between brain structural changes and fatigue in early MS.
    Nourbakhsh B; Azevedo C; Nunan-Saah J; Maghzi AH; Spain R; Pelletier D; Waubant E
    Mult Scler Relat Disord; 2016 Jan; 5():29-33. PubMed ID: 26856940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between cognitive and clinical disability across MS subtypes: The role of the underlying brain damage.
    Gois LCP; Pimentel-Silva LR; Damasceno BP; Damasceno A
    Mult Scler Relat Disord; 2021 Feb; 48():102701. PubMed ID: 33477004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic and Extrinsic Mechanisms of Thalamic Pathology in Multiple Sclerosis.
    Mahajan KR; Nakamura K; Cohen JA; Trapp BD; Ontaneda D
    Ann Neurol; 2020 Jul; 88(1):81-92. PubMed ID: 32286701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrinsic and extrinsic contributors to subregional thalamic volume loss in multiple sclerosis.
    Krijnen EA; Salim Karam E; Russo AW; Lee H; Chiang FL; Schoonheim MM; Huang SY; Klawiter EC
    Ann Clin Transl Neurol; 2024 Jun; 11(6):1405-1419. PubMed ID: 38725151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple sclerosis lesions and atrophy in the spinal cord: Distribution across vertebral levels and correlation with disability.
    Bussas M; El Husseini M; Harabacz L; Pineker V; Grahl S; Pongratz V; Berthele A; Riederer I; Zimmer C; Hemmer B; Kirschke JS; Mühlau M
    Neuroimage Clin; 2022; 34():103006. PubMed ID: 35468568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Serial 10-Year Follow-Up Study of Atrophied Brain Lesion Volume and Disability Progression in Patients with Relapsing-Remitting MS.
    Zivadinov R; Horakova D; Bergsland N; Hagemeier J; Ramasamy DP; Uher T; Vaneckova M; Havrdova E; Dwyer MG
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):446-452. PubMed ID: 30819766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attention and processing speed performance in multiple sclerosis is mostly related to thalamic volume.
    Bisecco A; Stamenova S; Caiazzo G; d'Ambrosio A; Sacco R; Docimo R; Esposito S; Cirillo M; Esposito F; Bonavita S; Tedeschi G; Gallo A
    Brain Imaging Behav; 2018 Feb; 12(1):20-28. PubMed ID: 28083844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease.
    Azevedo CJ; Cen SY; Khadka S; Liu S; Kornak J; Shi Y; Zheng L; Hauser SL; Pelletier D
    Ann Neurol; 2018 Feb; 83(2):223-234. PubMed ID: 29328531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.